Vimarsana
Biggest News Aggregation in the World

Page 30 - Nuclear Export News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nuclear Export. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nuclear Export Today - Breaking & Trending Today

Biology faculty and students attend American Society of Biochemistry and Molecular Biology meeting \ Westminster College - Vimarsana News

Biology faculty and students attend American Society of Biochemistry and Molecular Biology meeting \ Westminster College

Four Westminster College students and two faculty members recently attended the annual meeting of the American Society for Biochemistry and Molecular Biology (ASBMB) held April 2-5, 2022 in Philadelphia.

Karyopharm Therapeutics (NASDAQ:KPTI) Given New $10.00 Price Target at Canaccord Genuity Group - Vimarsana News

Karyopharm Therapeutics (NASDAQ:KPTI) Given New $10.00 Price Target at Canaccord Genuity Group

Karyopharm Therapeutics (NASDAQ:KPTI – Get Rating) had its target price reduced by Canaccord Genuity Group from $20.00 to $10.00 in a research report released on Monday, The Fly reports. Several other equities research analysts have also commented on KPTI. StockNews.com began coverage on shares of Karyopharm Therapeutics in a research report on Thursday, March 31st. […]

Karyopharm to Participate at the Canaccord Genuity Horizons in Oncology Conference - Vimarsana News

Karyopharm to Participate at the Canaccord Genuity Horizons in Oncology Conference

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

Karyopharm Therapeutics (NASDAQ:KPTI) Trading 4.2% Higher - Vimarsana News

Karyopharm Therapeutics (NASDAQ:KPTI) Trading 4.2% Higher

Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) shares traded up 4.2% on Thursday . The stock traded as high as $7.74 and last traded at $7.66. 11,834 shares were traded during mid-day trading, a decline of 100% from the average session volume of 3,780,177 shares. The stock had previously closed at $7.35. Several research analysts […]